Skip Nav Destination

Literature Scan

New and noteworthy research from the medical literature landscape

Straight-to-Transplantation Approach Comparable to Remission Induction in Difficult Acute Myeloid Leukemia Cases

Thomas R. Collins

Model Predicts the Need for Bone Marrow Sampling in Patients with MGUS

Lara C. Pullen, PhD

AI Electrocardiography Predicts Atrial Fibrillation Risk in Patients with CLL

Lara C. Pullen, PhD

CDC Guideline Results in Drop in Opioid Prescriptions for Patients with Sickle Cell Disease

Anna Azvolinsky, PhD

Apixaban Fails to Prevent Recurrence after Cryptogenic Stroke With Atrial Cardiopathy

Lara C. Pullen, PhD

Hepcidin Mimetic Rusfertide Nearly Eliminates Need for Phlebotomies in PV

Leah Lawrence

Gilteritinib Effective for Post-Transplant Maintenance for Acute Myeloid Leukemia

Lara C. Pullen, PhD

Cross-Trial Comparison Analyses in R/R Multiple Myeloma

Thomas R. Collins

FLT3-Mutated AML Responds Favorably to Triplet Regimen Including Inhibitor

Khylia Marshall

Cost-Benefit Analysis Favorable but Challenging for Gene Therapy for SCD

Ruth Jessen Hickman, MD

Belantamab Mafodotin Induces Durable Response When Combined With Pom-Dex, Despite Ocular Effects

Thomas R. Collins

Apixaban No Better Than Aspirin for Treatment of Embolic Stroke of Undetermined Source

Leah Lawrence

Statin Use Linked to Reduced Heart Failure, Risk of Death Among Patients with Non-Hodgkin Lymphoma

Anna Azvolinsky, PhD

Genomic Model Predicts Outcomes Better Than Existing Prognostic Methods in Newly Diagnosed Multiple Myeloma

Khylia Marshall

Mobile Apps Tackle High Rates of Depression, Chronic Pain in Sickle Cell Disease

Ruth Jessen Hickman, MD

Rituximab Maintenance Confers Most Benefit in MRD-Negative MCL

Leah Lawrence

Imetelstat Produces RBC Transfusion Independence in Lower-Risk Myelodysplastic Syndromes

Thomas R. Collins

Daratumumab Effective as Adjunctive Maintenance Therapy for Multiple Myeloma

Lara C. Pullen, PhD

IKZF1 Alterations an Independent Marker of AML Risk

Leah Lawrence

Study Proposes Recommendations for Infections During Teclistamab Treatment of R/R MM

Katie Robinson

1 2 3 4 5

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
Mid-July 2024

Advertisement intended for health care professionals

Literature Scan

ASH Publications

American Society of Hematology

Literature Scan

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only